#Japan #Tokyo #Healthcare Innovations #medical software #Holoeyes

Holoeyes Raises Approximately 230 Million Yen in Series B Funding

Holoeyes Inc., based in Minato City, Tokyo, has successfully raised around 230 million yen in a Series B extension round. This funding will propel the company's endeavors in enhancing their medical image processing software, Holoeyes MD, and further solidify their position in the healthcare industry.

The investment comes primarily from Teikyo Knowledge Initiative Co., Ltd. and Wacom Co., as well as contributions from individual investors including medical professionals. This substantial funding is aimed at enriching several key areas:

1. Talent Investment for Reimbursement Eligible Products: A significant portion of the funds will focus on recruiting skilled professionals vital for developing products eligible for additional compensation under medical coding systems.

2. Strengthening Collaborative Networks with Medical Institutions: Holoeyes plans to enhance existing partnerships with healthcare facilities, aiming to improve the implementation and adoption of their products within medical practices.

3. Driving Enterprise Business Through Collaborations with Corporates: The company aims to partner with various businesses to expand its enterprise solutions, leveraging their software's capabilities for a range of applications.

4. Accelerating Overseas Expansion in Regions like the Middle East: Holoeyes also aims to broaden its market reach by accelerating initiatives in key international markets, particularly in the Middle East region, including Saudi Arabia.

Recognition as a Venture Start-up

Recently, Holoeyes received recognition as a venture start-up affiliated with Teikyo University, a title that underlines its commitment to innovation in healthcare. With this funding and newfound recognition, Holoeyes is determined to foster collaborations with firms in pharmaceuticals, medical devices, and education sectors to generate value both domestically and internationally. The company also intends to pursue diverse strategic fundraising approaches, including capital alliances with corporate partners.

CEO Message

CEO Masaki Sugimoto expressed his gratitude by stating, "We deeply appreciate the substantial support from our investors and all stakeholders who continually recognize our efforts. Holoeyes has been dedicated to developing medical software grounded in spatial computing technology, allowing for intuitive visualization of medical images in three-dimensional models. This is aimed at enhancing decision support and information sharing in medical settings."

Going forward, Holoeyes is committed to intensifying its collaboration with medical institutions in Japan while steadily advancing its international ventures. The company is also enthusiastic about creating new business values in the enterprise domain through partnerships with firms across pharmaceuticals, medical devices, and educational sectors.

Vision for Future Development

Holoeyes strives to transform tacit knowledge accumulated in medical practices into visible and actionable knowledge, fostering efficiency and optimization within healthcare systems. Moreover, their mission includes contributing to the transformation of work practices for healthcare professionals through innovative technologies.

In closing, Holoeyes is dedicated to advancing technology development rooted in the medical field and promoting practical applications that lead to sustainable and high-quality healthcare. The company looks forward to continued support and guidance from all quarters as it embarks on this exciting journey.

About Holoeyes

Holoeyes was founded in October 2016 with a vision to optimize healthcare by spatially reproducing and sharing medical images and knowledge. The company develops virtual reality applications for clinical and educational use in the medical domain, alongside data provision services. Their flagship product, Holoeyes MD, which received medical device certification in 2020, enables the display of medical images in 3D space and is now utilized across approximately 200 medical specialties worldwide, including surgical and dental practices.

• - Location: 2-17-3 Minami Aoyama, Minato-ku, Tokyo, Mori Building 303
• - Founded: October 2016
• - CEO: Masaki Sugimoto
• - Capital: 214,375,000 yen
• - Website: Holoeyes

Holoeyes is also recognized as a selected company under the J-Startup program, which supports innovative startups seeking to make a global impact through various incentives. For more info, visit the J-Startup official website.